Q2 2025 · 13F-HR
Yorkville Advisors Global, LPholdings as filed
Filed 2025-11-21 · accession 0001104659-25-114981
$346.0M
Reported value
22
Positions
2025-06-30
Period end
The Brief · Yorkville Advisors Global, LP · Q2 2025
AI · grounded in 13F
Yorkville Advisors Global, LP established a new position in Trump Media & Technology Group DJT valued at $175.0M. The fund also initiated a new stake in Sequans Communications SA SQNS for $150.3M. Additional new positions include Sangamo Therapeutics Inc SGMO at $11.9M and Murano Global Investments PLC MRNO at $2.7M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 25400Q105 | DJT | Trump Media & Technology Group | $175.0M | 50.6% | 9,700,862 | Common | SOLE |
| 817323306 | SQNS | Sequans Communications SA | $150.3M | 43.5% | 10,227,115 | Common | SOLE |
| 800677106 | SGMO | Sangamo Therapeutics Inc | $11.9M | 3.44% | 22,000,000 | Common | SOLE |
| G63369105 | MRNO | Murano Global Investments PLC | $2.7M | 0.77% | 253,070 | Common | SOLE |
| 550424303 | LAZRQ | Luminar Technologies, Inc | $1.2M | 0.34% | 405,926 | Common | SOLE |
| 67021W301 | BURU | Nuburu Inc | $931,770 | 0.27% | 2,665,246 | Common | SOLE |
| 31573L105 | FBLG | FibroBiologics Inc | $525,201 | 0.15% | 844,103 | Common | SOLE |
| 895970101 | ILLR | Triller Group Inc | $447,036 | 0.13% | 480,426 | Common | SOLE |
| 03771D102 | APUS | Apimeds Pharmaceutical US Inc | $440,000 | 0.13% | 250,000 | Common | SOLE |
| 19207A207 | — | Coeptis Therapeutic Holdings Inc | $411,247 | 0.12% | 52,724 | Common | SOLE |
| 151190204 | CELU | Celularity Inc | $392,000 | 0.11% | 200,000 | Common | SOLE |
| 80512Q402 | — | N2OFF Inc | $346,305 | 0.10% | 1,505,675 | Common | SOLE |
| 553745308 | LIFWUSD | MSP Recovery, Inc | $319,700 | 0.09% | 230,000 | Common | SOLE |
| 58471K202 | MDCX | Medicus Pharma Ltd | $316,462 | 0.09% | 105,840 | Common | SOLE |
| 29414V209 | ADOMEUR | Envirotech Vehicles, Inc. | $223,750 | 0.06% | 1,250,000 | Common | SOLE |
| G75398900 | — | Rezolve AI PLC | $182,000 | 0.05% | 2,000 | CALL | SOLE |
| M74240108 | NRSN | Neurosense Therapeutics Ltd | $113,400 | 0.03% | 60,000 | Common | SOLE |
| 09073Q303 | SCNI | Scinai Immunotherapeutics Ltd | $95,760 | 0.03% | 42,000 | Common | SOLE |
| 25400Q955 | — | Trump Media & Technology Group | $49,750 | 0.01% | 11,641,500 | PUT | SOLE |
| 345523203 | FRSXUSD | Foresight Autonomous Holdings Ltd | $46,500 | 0.01% | 100,000 | Common | SOLE |
| G72007134 | XTKG | X3 Holdings Co Ltd | $28,709 | 0.01% | 17,831 | Common | SOLE |
| G3121H103 | EHGO | Eshallgo Inc | $18,170 | 0.01% | 23,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.